Kbc Group Nv Azenta, Inc. Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Azenta, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 2,137 shares of AZTA stock, worth $59,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,137

Previous 1,439 48.51%

Holding current value

$59,023

Previous $70,000 52.86%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$40.37 - $51.57 $28,178 - $35,995	698 Added 48.51%	2,137 $107,000
Q4 2023 Feb 13, 2024	BUY	$44.02 - $66.3 $63,344 - $95,405	1,439 New	1,439 $94,000
Q3 2023 Feb 15, 2024	BUY	$44.08 - $57.76 $5,686 - $7,451	129 Added 8.96%	1,568 $79,000
Q4 2021 Feb 03, 2022	SELL	$92.98 - $124.15 $242,491 - $323,783	-2,608 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$66.32 - $90.93 $111,881 - $153,398	1,687 Added 183.17%	2,608 $213,000
Q4 2020 Feb 10, 2021	BUY	$46.7 - $75.22 $43,010 - $69,277	921 New	921 $62,000
Q1 2020 May 04, 2020	SELL	$22.69 - $44.14 $188,871 - $367,421	-8,324 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$35.49 - $48.05 $743,728 - $1.01 Million	-20,956 Reduced 71.57%	8,324 $349,000
Q1 2019 May 10, 2019	BUY	$24.38 - $33.75 $72,116 - $99,832	2,958 Added 11.24%	29,280 $0
Q2 2018 Aug 03, 2018	SELL	$24.88 - $36.36 $129,450 - $189,181	-5,203 Reduced 16.5%	26,322 $0
Q1 2018 May 09, 2018	SELL	$23.3 - $30.15 $413,342 - $534,861	-17,740 Reduced 36.01%	31,525 $0
Q3 2017 Nov 13, 2017	BUY	$22.6 - $30.36 $1.11 Million - $1.5 Million	49,265	49,265 $0

Others Institutions Holding AZTA

# of Institutions

333

Shares Held

51.4M

Call Options Held

237K

Put Options Held

302K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $2.07B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account